6
Oct
2026
Arcera
Exhibitor at CPHI Milan 2026 stand 14G50, Finished Dosage & Formulation
About Us
Categories
-
Country/Region:Switzerland
-
On CPHI since:2020
-
Certificates:2
-
Employees:1000 - 4999
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 14G50, Finished Dosage & Formulation
Products Featured at CPHI Milan 2026
-
Product Finished Dosage Form
modified-release tablets (MUPS and matrix tablets)film coated- or dispersible tabletsprinted tabletsmodified release capsulesmicro-tablets in capsulescontrolled substances & broad-spectrum antibioticssugar coated tablets -
Product Out-Licensing
Acino is a Swiss-based company that offers high quality generic products in advanced drug delivery systems. Special focus is on narcotics and extended release formulations as part of our long-term strategy to expand the product portfolio within Oncology, Urology or Pain. The products are manufactured in ou... -
Product Granulation/Pelletization
wet (aqueous & organic), dry and melt granulationfluid-bed & high shear granulationdirect compressionextrusion / spheronizationpellet layering in fluid bed processcoating of pellets fluid.bed and tray dryingsieving / blending -
Product Primary packaging
PVC // AluPVC/PVDC // AuPVC/PE/PVDC // AluAlu // Alucontrolled substances packagingpackaging of potent OSDsbottles (glass, plastic, aluminium) with different caps (push-on, screw, snap safe, desiccant capsules)unit dose blister -
Product Contract Manufacturing Services
As a Swiss pharmaceutical manufacturer, Acino can look back on to a long history in producing oral solid dosage forms for major generic companies at the highest quality possible. Having developed profound know-how within this field, Acino has a well-known track record in manufacturing complex modified...




